NGC - Search Results

Welcome to NGC. Skip directly to: Search Box, Navigation, Content.

NGC Search Results

Search Help | Guideline Comparison Help | Guideline Views | Quick Search Tips

Your search criteria:

Disease/Condition: "colorectal cancer" OR "colorectal neoplasms" OR "colon cancer" OR "colonic neoplasms"
Guideline Categories: Management, Treatment
Sort Order: Relevance

Your search found 29 related guidelines, which are listed below by relevance. Use the "Limit Search" button to sort by publication date.

To view a guideline summary, click on a title below.

Items 1 to 20

	Title
	Management of colorectal cancer. A national clinical guideline. Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. 2003 Mar. 47 pages. NGC:002950 Other Guidelines from this Developer
	Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). American Society of Colon and Rectal Surgeons - Medical Specialty Society. 2003 Aug. 12 pages. NGC:003798 Other Guidelines from this Developer
	Surveillance and management of groups at increased risk of colorectal cancer. New Zealand Guidelines Group - Private Nonprofit Organization. 2004 May. 84 pages. NGC:003655 Other Guidelines from this Developer
	Use of raltitrexed (Tomudex) in the management of metastatic colorectal cancer. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. 1998 May 22 (revised 2005 Feb). 13 pages. NGC:004434 Other Guidelines from this Developer
	Colorectal cancer. Singapore Ministry of Health - National Government Agency [Non-U.S.]. 2004 Feb. 85 pages. NGC:003489 Other Guidelines from this Developer
	Practice parameters for colon cancer. American Society of Colon and Rectal Surgeons - Medical Specialty Society. 2004 Aug. 16 pages. NGC:003956 Other Guidelines from this Developer
	Laparoscopic surgery for colorectal cancer (review). National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2006 Aug. 25 pages. NGC:005409 Other Guidelines from this Developer
	Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2005 Aug. 39 pages. NGC:005418 Other Guidelines from this Developer
	Guidelines for the management of colorectal cancer. Association of Coloproctology of Britain and Ireland - Medical Specialty Society. 2001 (revised 2007). 117 pages. NGC:005904 Other Guidelines from this Developer
	The role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first and second-line treatment of advanced colorectal cancer: a clinical practice guideline. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. 2005 (revised 2006 Dec). 33 pages. NGC:006242 Other Guidelines from this Developer
	Guidelines for laparoscopic resection of curable colon and rectal cancer. American Society of Colon and Rectal Surgeons - Medical Specialty Society Society of American Gastrointestinal and Endoscopic Surgeons - Medical Specialty Society. 2005 Jul. 12 pages. NGC:005294 Other Guidelines from this Developer
	Follow-up of patients with curatively resected colorectal cancer. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. 2002 Jun (revised online 2004 Jan). 30 pages. NGC:003459 Other Guidelines from this Developer
	Use of irinotecan (Camptosar®, CPT-11) combined with 5-fluorouracil and leucovorin (5FU/LV) as first-line therapy for metastatic colorectal cancer. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. 2001 Oct 23 (updated online 2003 Feb). 20 pages. NGC:002989 Other Guidelines from this Developer
	ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. American Society of Clinical Oncology - Medical Specialty Society. 1996 (revised 2006 Nov 20). 15 pages. NGC:005328 Other Guidelines from this Developer
	Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2003 May. 25 pages. NGC:004911 Other Guidelines from this Developer
	Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes’ C) colon cancer. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2006 Apr. 34 pages. NGC:005415 Other Guidelines from this Developer
	Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2007 Jan. 34 pages. NGC:005509 Other Guidelines from this Developer
	Practice parameters for the surgical treatment of ulcerative colitis. American Society of Colon and Rectal Surgeons - Medical Specialty Society. 1997 (revised 2005 Nov). 13 pages. NGC:005612 Other Guidelines from this Developer
	The role of Bevacizumab (Avastin®) combined with chemotherapy in the treatment of patients with advanced colorectal cancer: a clinical practice guideline. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. 2005 Dec 12 (revised 2007 Nov 19). 31 pages. NGC:006314 Other Guidelines from this Developer
	ASGE guideline: the role of endoscopy in the diagnosis, staging, and management of colorectal cancer. American Society for Gastrointestinal Endoscopy - Medical Specialty Society. 2005 Jan. 7 pages. NGC:004061 Other Guidelines from this Developer

Browse

» Disease / Condition
» Treatment / Intervention
» Measures
» Organization
» Guideline Index
» Guidelines In Progress
» Guideline Archive

Compare

» View My Collection
» Guideline Syntheses

Search
Browse
Compare
Resources

Date Modified: 9/15/2008